CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Jiangsu Sihuan Bioengineering Co., Ltd. Company Snapshot
Jiangsu Sihuan Bioengineering Co., Ltd. operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Jiangsu Sihuan Bioengineering Co., Ltd. with three other companies in this sector in China: Zhejiang Wolwo Bio Pharmaceutical Co Ltd (2016 sales of 312.09 million Chinese Renmimbi [US$45.69 million] of which 100% was Pharmaceutical Manufacturing), Shanghai Jiaoda Onlly Co., Ltd. (268.22 million Chinese Renmimbi [US$39.27 million] of which 90% was Commerce), and Shanghai Hile Bio-Technology Co Ltd (343.20 million Chinese Renmimbi [US$50.25 million] of which 100% was Veterinary Biological Products).

Sales Analysis. During the year ended December of 2016, sales at Jiangsu Sihuan Bioengineering Co., Ltd. were 326.95 million Chinese Renmimbi (US$47.87 million). This is an increase of 37.9% versus 2015, when the company's sales were 237.03 million Chinese Renmimbi. Sales of Pharmaceutical Products saw an increase of 35.7% in 2016, from 232.76 million Chinese Renmimbi to 315.83 million Chinese Renmimbi. Not all segments of Jiangsu Sihuan Bioengineering Co., Ltd. experienced an increase in sales in 2016: sales of Other Industry fell 20.2% to 4.05 million Chinese Renmimbi. (However, this segment's sales were only a very small portion of the company's overall sales).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Jiangsu Sihuan Bioengineering Co., Ltd.
  Stock Performance Chart for Jiangsu Sihuan Bioengineering Co., Ltd.
 
  Stock Data: Recent Stock Performance:
  Current Price (6/23/2017): 7.08
(Figures in Chinese Renmimbi)
1 Week -1.1%   13 Weeks 0.9%  
4 Weeks -12.6%   52 Weeks 6.3%  
 
Jiangsu Sihuan Bioengineering Co., Ltd. Key Data:
  Ticker: 000518 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2016 Sales 326,946,335
(Year Ending Jan 2017).
Employees: 413
  Currency: Chinese Renmimbi Market Cap: 7,289,258,052
  Fiscal Yr Ends: December Shares Outstanding: 1,029,556,222
  Share Type: A Gu Closely Held Shares: 552,222,901
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.